Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPs 7630 tablets for acute rhinopharyngitis in adults
2007-005797-31Phase 3Active
- Sponsor
- Schwabe Group
- Start
- Aug 2008
- Countries
- 1
01
Overview
Phase 3 trial of pelargonium sidoides extract in nasopharyngitis, sponsored by Schwabe Group. Primary endpoint: Area under the curve of total rhinopharyngitis-relevant symptom score. Started Aug 2008; status: active.
02
Drugs
pelargonium sidoides extract
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on 2007-005797-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005797-31.